NCT03808090View on ClinicalTrials.gov

Obesity and Endogenous Oxalate Synthesis

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

July 1, 2023

Study Completion Date

July 31, 2024

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Normal Individuals

"Controlled Dietary phase: Low oxalate fixed diet~4 days of fixed normal calorie diet with low oxalate (\< 60 mg/day), normal calcium (800-1200 mg/day)"

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT03808090 - Obesity and Endogenous Oxalate Synthesis | Biotech Hunter | Biotech Hunter